Intelligent Bio Solutions... (INBS)
1.29
-0.03 (-2.27%)
At close: Jan 14, 2025, 3:59 PM
1.32
1.93%
Pre-market Jan 15, 2025, 05:35 AM EST
undefined% (undefined)
| Bid | 1.3 |
| Market Cap | 6.23M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.3 |
| PE Ratio (ttm) | -0.56 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.35 |
| Volume | 47,426 |
| Avg. Volume (20D) | 118,195 |
| Open | 1.33 |
| Previous Close | 1.32 |
| Day's Range | 1.28 - 1.33 |
| 52-Week Range | 1.00 - 11.70 |
| Beta | undefined |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
Next Earnings Release
Intelligent Bio Solutions Inc. is scheduled to release its earnings on Feb 7, 2025,
before market opens.
Analysts project revenue of $2.25M, reflecting a 194.48% YoY growth and earnings per share of -0.32, making a -84.54% decrease YoY.
Analysts project revenue of $2.25M, reflecting a 194.48% YoY growth and earnings per share of -0.32, making a -84.54% decrease YoY.
3 months ago ·
Source
-17.81%
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
4 months ago ·
Source
+13.29%
Intelligent Bio Solutions shares are trading higher after the company announced preliminary Q4 revenue results of $730K and FY24 revenue of $3.11 million.
